In early July 2025, Peijia Medical successfully hosted 2025 Corporate Day at its global headquarters in Suzhou Industrial Park. The event attracted over 150 investors and analysts to the site, collectively witnessing the solid progress of China’s medical device innovation.
The event began with a review of the company’s remarkable achievements in commercialization and R&D over the past five years. The management and business leaders then engaged in in depth discussions with attendees on future trends in innovative medical devices, focusing on two core areas: interventional therapy for peri-valvular disease and neurointervention, while also elaborating on Peijia’s latest development strategies.
When asked about the company’s market valuation expectations during the Q&A session, Dr. Zhang Yi smiled and responded that Peijia would remain focused on fulfilling its responsibilities, time will prove our value. His pragmatic and dedicated attitude drew warm applause from the audience.
Looking ahead, Peijia Medical will continue to uphold its values of “Dedication with Passion, Devotion for Life” adhere to clinical needs, deepen lean management, optimize the supply chain system, and enable more innovative medical technologies to benefit patients in China and around the world. In the vast journey of medical technology innovation, Peijia Medical is advancing with steadfast steps toward its vision of “becoming a globally leading innovative medical device platform”.
For more information, please visit: https://mp.weixin.qq.com/s/fZevvNrRZL1Mq0L_OAIk_g
